Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
4.790
+0.050 (1.05%)
At close: Dec 5, 2025, 4:00 PM EST
4.880
+0.090 (1.88%)
After-hours: Dec 5, 2025, 5:42 PM EST
Anixa Biosciences Employees
As of October 31, 2024, Anixa Biosciences had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,223,000
Market Cap
157.67M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANIX News
- 18 days ago - Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript - Seeking Alpha
- 19 days ago - Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization - PRNewsWire
- 24 days ago - Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat - GlobeNewsWire
- 24 days ago - Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s - PRNewsWire
- 26 days ago - Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 - PRNewsWire
- 4 weeks ago - Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic - PRNewsWire
- 6 weeks ago - Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference - PRNewsWire
- 6 weeks ago - Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology - PRNewsWire